Login / Signup

Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder.

Nour K KadouhStacy LangMark ShamounEric L ScottSharon A SinghMichael A Smith
Published in: Pediatric blood & cancer (2021)
Keyphrases
  • autism spectrum disorder
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • chronic pain
  • early stage
  • prognostic factors
  • neuropathic pain
  • intellectual disability
  • postoperative pain